PAVING THE WAY FOR AN ALS TREATMENT

By digging deeper into the cause of amyotrophic lateral sclerosis (ALS), and investigating its various pathologies, we are developing precision medications to effectively treat ALS and frontotemporal dementia.

ALS Progression

ALS PATIENTS

ALS has a devastating impact on patients and families. Through DNA analysis and clinical studies, we now know that there are several distinct ALS pathologies that must be treated individually to achieve success. Through our work with ALS patient-derived stem cells, our close collaborators in the clinic and the worldwide ALS research community, we have identified the disease cause for three distinct ALS pathologies – motor system hyperactivity, toxic protein aggregates, and cellular waste clearance. 
For ALS patients in the Tri-state area, please visit the website of the MAC Angels for more information and support: https://www.macangels.org/

ALS Natural Treatment

OUR MISSION

ALS can affect anyone and with no meaningful treatment options, the predicted life expectancy following diagnosis is roughly 3 years. Our mission at QurAlis is to use the latest advances in drug design and precision medicine to develop clinically meaningful treatments for ALS that will provide much-needed hope to patients that we can eventually conquer this disease.